论药品可及性与药品专利保护  

On Accessibility and Patent Protection of Drugs

作　　者：刘莹[1] 梁毅[1] 

机构地区：[1]中国药科大学国际医药商学院,南京市210009

出　　处：《中国药房》2007年第13期966-968,共3页China Pharmacy

摘　　要：目的:寻找保护我国目前创新能力尚未成熟的民族制药业的途径,并确保药品可及性。方法:利用需求弹性理论、健康权与专利权属性比较等方法,结合TRIPS协议和国外的相关实践进行分析。结果与结论:对于我国这样的发展中国家来说,首先应当优先考虑眼前急迫的需要,如满足人民群众用药需求;然后逐步满足长远的需要,如鼓励自主知识产权,因此应有步骤地完善药品专利制度中与药品可及性相关的制度。OBJECTIVE: To seek approach for the protection of domestic pharmaceutical enterprises with immature creativity and to ensure drug accessibility. METHODS: An analysis was performed applying the theory of demand elasticity by comparing the attributes of health right and patent right etc based on TRIPS protocol and the related practice abroad. RESULTS & CONCLUSIONS: For a developing country, China should give top priority to the short-term urgent needs, such as to meet people's medication demands, followed by ...

关 键 词：药品可及性 药品专利 健康权 保护 

分 类 号：F42[经济管理—产业经济]